BEHRENS M KATHLEEN bought SRPT
March 1, 2024 · Form 4 insider transaction
BEHRENS M KATHLEEN bought 1,846 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,846
Price
$0.00
Total value
N/A
InsiderBEHRENS M KATHLEEN
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 1, 2024
Filing dateMarch 5, 2024
Shares owned after176,839
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025.